American Herbal Products Association (AHPA) > News

AHPA recommends oshá harvest permitting in GMUG National Forests

Research supported by the AHPA ERB Foundation concludes plants have a high capacity for post‐harvest recolonization

AHPA recently submitted comments to the Grand Mesa, Uncompahgre and Gunnison (GMUG) National Forests to recommend that a revision of its plan for land and resource management include a process for permitting commercial harvest of oshá (Ligusticum porteri) root.

A Primer on AHPA’s Good Agricultural and Collection Practices and Good Manufacturing Practices (GACP-GMP) Guidance for Botanical Materials

What is AHPA's GACP-GMP guidance and how can it help your business?

Recorded May 22, 2018 -- Member cost: $150. Nonmember cost: $350.

AHPA endorses the Hemp Farming Act of 2018

AHPA Board adopts policy to support any state or federal efforts to decriminalize hemp

AHPA is endorsing federal legislation recently introduced to decriminalize hemp and the AHPA Board of Trustees has adopted a policy for the association to support any future state or federal legislation to decriminalize the plant and all its derivatives.

IADSA update on international supplement regulations

IADSA April 2018 Newsflash

This issue of the IADSA Newsflash includes an update on EFSA's proposed limit of 800 mg/day for the intake of green tea catechins in food supplements

AHPA ERB Foundation expands board with additions of Steven Dentali and Susan Leopold

ERB Foundation promotes education and research on medicinal, therapeutic, and health-promoting herbs

The AHPA Foundation for Education and Research on Botanicals (ERB Foundation) is pleased to announce the expansion of its board of directors with the additions of Steven Dentali, Ph.D., and Susan Leopold, Ph.D., executive director at United Plant Savers (UpS).

AHPA President Michael McGuffin urges companies selling kratom to comply with all applicable laws and regulations

Statement delivered during press conference

AHPA President Michael McGuffin stressed that any company looking to sell kratom or kratom products must comply with all applicable laws and regulations during a press conference.

AHPA recommends CBD not be scheduled under any international drug control convention

AHPA submits comments to FDA to inform participation in WHO Expert Committee on Drug Dependence

AHPA submitted comments to the Food and Drug Administration (FDA) yesterday to stress that cannabidiol (CBD) requires no international drug scheduling as an individual substance and encourage the U.S. to support this position.

Rate of NDI notifications reported by FDA unexpectedly drops

More than half of most recent NDI notifications available from FDA filed without comment

More than half of the most recent new dietary ingredient (NDI) notifications provided by the Food and Drug Administration (FDA) in the last six months were filed without comment, but the rate of notifications reported received by the agency is dramatically lower than previously observed for any six month period since the initial six months in 1995 when the agency first began accepting and filing notifications.

AHPA meetings and events at Natural Products Expo West

AHPA Annual Member meeting, reception, awards, committee meetings and more!

March 5-8, 2018 -- Anaheim Convention Center, California

AHPA supports FDA Guidance making pure or highly concentrated caffeine dietary supplements unlawful

AHPA policy prohibits the sale of pure caffeine

FDA issued guidance titled, "Highly Concentrated Caffeine in Dietary Supplements: Guidance for Industry," to explain that it generally considers pure or highly concentrated caffeine dietary supplements, sold in bulk directly to consumers, to be adulterated because they present a significant or unreasonable risk of illness or injury. The principle in this guidance is consistent with a policy adopted by AHPA members in 2015.

AHPA Updates

Subscribe >>